News und Analysen

0

DGAP-News: Eckert & Ziegler erweitert Liefervertrag mit Sirtex Medical auf chinesischen Markt

0

DGAP-News: Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market

0

DGAP-News: Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market

0

DGAP-News: Eckert & Ziegler erweitert Liefervertrag mit Sirtex Medical auf chinesischen Markt

0

DGAP-News: Eckert & Ziegler liefert Lutetium-177 für klinische Studien von Telix

0

DGAP-News: Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials

0

DGAP-News: Eckert & Ziegler liefert Lutetium-177 für klinische Studien von Telix

0

DGAP-News: Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials

0

DGAP-Adhoc: Eckert & Ziegler unterzeichnet exklusiven Liefervertrag für Ytterbium-176

0

DGAP-Adhoc: Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176

0

DGAP-Adhoc: Eckert & Ziegler unterzeichnet exklusiven Liefervertrag für Ytterbium-176

0

DGAP-Adhoc: Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176

0

DGAP-Adhoc: Eckert & Ziegler kauft argentinischen SPECT-Spezialisten

0

DGAP-Adhoc: Eckert & Ziegler kauft argentinischen SPECT-Spezialisten

0

DGAP-Adhoc: Eckert & Ziegler Acquires Argentinian SPECT Specialist

0

DGAP-Adhoc: Eckert & Ziegler Acquires Argentinian SPECT Specialist

0

DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application

0

DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application

0

DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR

0

DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR

0

3 companies that more than doubled analyst EPS estimates

Earnings season is well underway, and the winner-and-loser separation continues to grow. Of the companies that beat consensus analyst estimates, even fewer go well beyond and exceed analyst

0

Merck, the Dow's hottest stock, gets set to report Q4 financials

Dow Jones Industrial Average (DJIA) stalwart Merck & Co., Inc. (NYSE:MRK) has momentum on its side heading into its February 1st earnings report.

Shares of the large cap pharmaceutical company

0

Are defensive sectors ready to outshine growth in 2024?

Defensive sectors are off to a better start to the new year than growth stocks, which dominated in 2023.

The Health Care Select Sector SPDR Fund (NYSEARCA: XLV), which has both growth and

0

PetVivo Sales Spryng Higher on Injectable OA Relief for Pets

Developmental biomedical device company PetVivo Holdings Inc. (OTCMKTS: PETV) makes pet medical devices and therapeutics. What kind of medical devices would pets need? Pacemakers? Artificial hearts